Zobrazeno 1 - 10
of 107
pro vyhledávání: '"Meijerink JP"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Canté-Barrett K; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Meijer MT; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Cordo' V; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Hagelaar R; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Yang W; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Yu J; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Smits WK; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Nulle ME; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Jansen JP; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Pieters R; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Yang JJ; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Haigh JJ; Research Institute in Oncology and Hematology, CancerCare Manitoba, Winnipeg, Manitoba, Canada.; Department of Pharmacology and Therapeutics, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada., Goossens S; Biomolecular Medicine, Ghent University, Ghent, Belgium., Meijerink JP; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Publikováno v:
JCI insight [JCI Insight] 2022 Jul 08; Vol. 7 (13). Date of Electronic Publication: 2022 Jul 08.
Autor:
Bodaar K; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA., Yamagata N; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA., Barthe A; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA., Landrigan J; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA., Chonghaile TN; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA.; Deparment of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland., Burns M; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA., Stevenson KE; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Devidas M; Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, USA., Loh ML; Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, and the Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA, 98105, USA., Hunger SP; Division of Oncology and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA., Wood B; Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA, 90027, USA., Silverman LB; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA., Teachey DT; Division of Oncology and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA., Meijerink JP; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands., Letai A; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA., Gutierrez A; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA. alejandro.gutierrez@childrens.harvard.edu.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA. alejandro.gutierrez@childrens.harvard.edu.
Publikováno v:
Leukemia [Leukemia] 2022 Jun; Vol. 36 (6), pp. 1499-1507. Date of Electronic Publication: 2022 Apr 11.
Autor:
Butler M; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Laboratory of Pediatric Oncology, Department of Pediatrics, and., van Ingen Schenau DS; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands., Yu J; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands Radboud University Medical Center, Nijmegen, The Netherlands., Jenni S; Department of Pediatric Oncology, Children's Research Centre, University Children's Hospital Zurich, Zurich, Switzerland., Dobay MP; Department of Pediatric Oncology, Children's Research Centre, University Children's Hospital Zurich, Zurich, Switzerland., Hagelaar R; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands., Vervoort BMT; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands., Tee TM; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands., Hoff FW; Department of Leukemia and Department of Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, Houston, TX.; Department of Pediatric Oncology/Hematology, Beatrix Children's Hospital University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; and., Meijerink JP; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands., Kornblau SM; Department of Leukemia and Department of Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, Houston, TX., Bornhauser B; Department of Pediatric Oncology, Children's Research Centre, University Children's Hospital Zurich, Zurich, Switzerland., Bourquin JP; Department of Pediatric Oncology, Children's Research Centre, University Children's Hospital Zurich, Zurich, Switzerland., Kuiper RP; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands., van der Meer LT; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands., van Leeuwen FN; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Publikováno v:
Blood [Blood] 2021 Dec 09; Vol. 138 (23), pp. 2383-2395.
Autor:
Belver L; Institute for Cancer Genetics, Columbia University, New York, New York., Yang AY; Institute for Cancer Genetics, Columbia University, New York, New York., Albero R; Institute for Cancer Genetics, Columbia University, New York, New York., Herranz D; Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, New Jersey.; Department of Pharmacology, Robert Wood Johnson Medical School, Rutgers University, Piscataway, New Jersey., Brundu FG; Department of Systems Biology, Columbia University, New York, New York., Quinn SA; Institute for Cancer Genetics, Columbia University, New York, New York., Pérez-Durán P; Institute for Cancer Genetics, Columbia University, New York, New York., Álvarez S; Institute for Cancer Genetics, Columbia University, New York, New York., Gianni F; Institute for Cancer Genetics, Columbia University, New York, New York., Rashkovan M; Institute for Cancer Genetics, Columbia University, New York, New York., Gurung D; Institute for Cancer Genetics, Columbia University, New York, New York., Rocha PP; Division of Developmental Biology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, Maryland., Raviram R; Ludwig Institute for Cancer Research, La Jolla, California.; Department of Chemistry and Biochemistry, University of California, San Diego, La Jolla, California., Reglero C; Institute for Cancer Genetics, Columbia University, New York, New York., Cortés JR; Institute for Cancer Genetics, Columbia University, New York, New York., Cooke AJ; Institute for Cancer Genetics, Columbia University, New York, New York., Wendorff AA; Institute for Cancer Genetics, Columbia University, New York, New York., Cordó V; Department of Pediatric Oncology/Hematology, Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands., Meijerink JP; Department of Pediatric Oncology/Hematology, Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands., Rabadan R; Department of Pharmacology, Robert Wood Johnson Medical School, Rutgers University, Piscataway, New Jersey.; Department of Biomedical Informatics, Columbia University, New York, New York., Ferrando AA; Institute for Cancer Genetics, Columbia University, New York, New York. af2196@columbia.edu.; Department of Pharmacology, Robert Wood Johnson Medical School, Rutgers University, Piscataway, New Jersey.; Department of Pediatrics, Columbia University Medical Center, New York, New York.; Department of Pathology, Columbia University Medical Center, New York, New York.
Publikováno v:
Cancer discovery [Cancer Discov] 2019 Dec; Vol. 9 (12), pp. 1774-1791. Date of Electronic Publication: 2019 Sep 13.
Autor:
Gachet S; INSERM UMR944 and CNRS UMR7212, Hôpital Saint-Louis, Paris, France.; Institute of Hematology (IUH), Université Paris Diderot, Sorbonne Paris Cité, Paris, France., El-Chaar T; INSERM UMR944 and CNRS UMR7212, Hôpital Saint-Louis, Paris, France.; Institute of Hematology (IUH), Université Paris Diderot, Sorbonne Paris Cité, Paris, France., Avran D; INSERM UMR944 and CNRS UMR7212, Hôpital Saint-Louis, Paris, France.; Institute of Hematology (IUH), Université Paris Diderot, Sorbonne Paris Cité, Paris, France.; Hematology Laboratory APHP, Hôpital Saint-Louis, Paris, France., Genesca E; INSERM UMR944 and CNRS UMR7212, Hôpital Saint-Louis, Paris, France.; Institute of Hematology (IUH), Université Paris Diderot, Sorbonne Paris Cité, Paris, France., Catez F; Centre de Recherche en Cancérologie de Lyon, INSERM U1052, CNRS 5286, Centre Léon Bérard; Université Lyon 1, Lyon, France., Quentin S; INSERM UMR944 and CNRS UMR7212, Hôpital Saint-Louis, Paris, France.; Institute of Hematology (IUH), Université Paris Diderot, Sorbonne Paris Cité, Paris, France.; Hematology Laboratory APHP, Hôpital Saint-Louis, Paris, France., Delord M; Institute of Hematology (IUH), Université Paris Diderot, Sorbonne Paris Cité, Paris, France., Thérizols G; Centre de Recherche en Cancérologie de Lyon, INSERM U1052, CNRS 5286, Centre Léon Bérard; Université Lyon 1, Lyon, France., Briot D; INSERM UMR944 and CNRS UMR7212, Hôpital Saint-Louis, Paris, France.; Institute of Hematology (IUH), Université Paris Diderot, Sorbonne Paris Cité, Paris, France.; Hematology Laboratory APHP, Hôpital Saint-Louis, Paris, France., Meunier G; INSERM UMR944 and CNRS UMR7212, Hôpital Saint-Louis, Paris, France.; Institute of Hematology (IUH), Université Paris Diderot, Sorbonne Paris Cité, Paris, France., Hernandez L; INSERM UMR944 and CNRS UMR7212, Hôpital Saint-Louis, Paris, France.; Institute of Hematology (IUH), Université Paris Diderot, Sorbonne Paris Cité, Paris, France., Pla M; Institute of Hematology (IUH), Université Paris Diderot, Sorbonne Paris Cité, Paris, France.; INSERM UMRS 940, Hôpital Saint-Louis, Paris, France., Smits WK; Department of Pediatric Oncology/Hematology, Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands., Buijs-Gladdines JG; Department of Pediatric Oncology/Hematology, Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands., Van Loocke W; Cancer Research Institute, Ghent University, Ghent, Belgium., Menschaert G; Cancer Research Institute, Ghent University, Ghent, Belgium., André-Schmutz I; U1163 INSERM, Université Paris Descartes-Sorbonne Paris Cité, Institut Imagine, Paris, France., Taghon T; Cancer Research Institute, Ghent University, Ghent, Belgium., Van Vlierberghe P; Cancer Research Institute, Ghent University, Ghent, Belgium., Meijerink JP; Department of Pediatric Oncology/Hematology, Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands., Baruchel A; Institute of Hematology (IUH), Université Paris Diderot, Sorbonne Paris Cité, Paris, France.; Hematology Pediatry Department, Robert Debré Hospital, Paris, France., Dombret H; Institute of Hematology (IUH), Université Paris Diderot, Sorbonne Paris Cité, Paris, France.; Hematology Department, Hôpital Saint-Louis, Paris, France., Clappier E; INSERM UMR944 and CNRS UMR7212, Hôpital Saint-Louis, Paris, France.; Institute of Hematology (IUH), Université Paris Diderot, Sorbonne Paris Cité, Paris, France.; Hematology Laboratory APHP, Hôpital Saint-Louis, Paris, France., Diaz JJ; Centre de Recherche en Cancérologie de Lyon, INSERM U1052, CNRS 5286, Centre Léon Bérard; Université Lyon 1, Lyon, France., Gazin C; Centre National de Recherche en Génomique Humaine (CNRGH), Institut de Biologie François Jacob, Direction de La Recherche Fondamentale, CEA, Evry, France., de Thé H; INSERM UMR944 and CNRS UMR7212, Hôpital Saint-Louis, Paris, France.; Institute of Hematology (IUH), Université Paris Diderot, Sorbonne Paris Cité, Paris, France., Sigaux F; INSERM UMR944 and CNRS UMR7212, Hôpital Saint-Louis, Paris, France.; Institute of Hematology (IUH), Université Paris Diderot, Sorbonne Paris Cité, Paris, France.; Hematology Laboratory APHP, Hôpital Saint-Louis, Paris, France., Soulier J; INSERM UMR944 and CNRS UMR7212, Hôpital Saint-Louis, Paris, France. jean.soulier@sls.aphp.fr.; Institute of Hematology (IUH), Université Paris Diderot, Sorbonne Paris Cité, Paris, France.; Hematology Laboratory APHP, Hôpital Saint-Louis, Paris, France.
Publikováno v:
Cancer discovery [Cancer Discov] 2018 Dec; Vol. 8 (12), pp. 1614-1631. Date of Electronic Publication: 2018 Sep 28.
Autor:
Vanden Bempt M; KU Leuven Center for Human Genetics, KU Leuven, Leuven, Belgium; VIB Center for Cancer Biology, VIB, Leuven, Belgium., Demeyer S; KU Leuven Center for Human Genetics, KU Leuven, Leuven, Belgium; VIB Center for Cancer Biology, VIB, Leuven, Belgium., Broux M; KU Leuven Center for Human Genetics, KU Leuven, Leuven, Belgium; VIB Center for Cancer Biology, VIB, Leuven, Belgium., De Bie J; KU Leuven Center for Human Genetics, KU Leuven, Leuven, Belgium; VIB Center for Cancer Biology, VIB, Leuven, Belgium., Bornschein S; KU Leuven Center for Human Genetics, KU Leuven, Leuven, Belgium; VIB Center for Cancer Biology, VIB, Leuven, Belgium., Mentens N; KU Leuven Center for Human Genetics, KU Leuven, Leuven, Belgium; VIB Center for Cancer Biology, VIB, Leuven, Belgium., Vandepoel R; KU Leuven Center for Human Genetics, KU Leuven, Leuven, Belgium; VIB Center for Cancer Biology, VIB, Leuven, Belgium., Geerdens E; KU Leuven Center for Human Genetics, KU Leuven, Leuven, Belgium; VIB Center for Cancer Biology, VIB, Leuven, Belgium., Radaelli E; KU Leuven Center for Human Genetics, KU Leuven, Leuven, Belgium., Bornhauser BC; Department of Oncology and Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland., Kulozik AE; Department of Pediatric Hematology and Oncology, Heidelberg University Children's Hospital, Heidelberg, Germany; Hopp Children's Cancer Center at the NCT Heidelberg, Heidelberg, Germany., Meijerink JP; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Bourquin JP; Department of Oncology and Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland., de Bock CE; KU Leuven Center for Human Genetics, KU Leuven, Leuven, Belgium; VIB Center for Cancer Biology, VIB, Leuven, Belgium. Electronic address: charles.debock@kuleuven.vib.be., Cools J; KU Leuven Center for Human Genetics, KU Leuven, Leuven, Belgium; VIB Center for Cancer Biology, VIB, Leuven, Belgium. Electronic address: jan.cools@kuleuven.vib.be.
Publikováno v:
Cancer cell [Cancer Cell] 2018 Aug 13; Vol. 34 (2), pp. 271-285.e7.
Autor:
de Bock CE; KU Leuven, Center for Human Genetics, Leuven, Belgium.; VIB, Center for Cancer Biology, Leuven, Belgium., Demeyer S; KU Leuven, Center for Human Genetics, Leuven, Belgium.; VIB, Center for Cancer Biology, Leuven, Belgium., Degryse S; KU Leuven, Center for Human Genetics, Leuven, Belgium.; VIB, Center for Cancer Biology, Leuven, Belgium., Verbeke D; KU Leuven, Center for Human Genetics, Leuven, Belgium.; VIB, Center for Cancer Biology, Leuven, Belgium., Sweron B; KU Leuven, Center for Human Genetics, Leuven, Belgium.; VIB, Center for Cancer Biology, Leuven, Belgium., Gielen O; KU Leuven, Center for Human Genetics, Leuven, Belgium.; VIB, Center for Cancer Biology, Leuven, Belgium., Vandepoel R; KU Leuven, Center for Human Genetics, Leuven, Belgium.; VIB, Center for Cancer Biology, Leuven, Belgium., Vicente C; KU Leuven, Center for Human Genetics, Leuven, Belgium.; VIB, Center for Cancer Biology, Leuven, Belgium., Vanden Bempt M; KU Leuven, Center for Human Genetics, Leuven, Belgium.; VIB, Center for Cancer Biology, Leuven, Belgium., Dagklis A; KU Leuven, Center for Human Genetics, Leuven, Belgium.; VIB, Center for Cancer Biology, Leuven, Belgium., Geerdens E; KU Leuven, Center for Human Genetics, Leuven, Belgium.; VIB, Center for Cancer Biology, Leuven, Belgium., Bornschein S; KU Leuven, Center for Human Genetics, Leuven, Belgium.; VIB, Center for Cancer Biology, Leuven, Belgium., Gijsbers R; Laboratory for Viral Vector Technology and Gene Therapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium., Soulier J; U944 INSERM and Hematology Laboratory, St-Louis Hospital, APHP, Hematology University Institute, University Paris-Diderot, Paris, France., Meijerink JP; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Heinäniemi M; Institute of Biomedicine, School of Medicine, University of Eastern Finland, Kuopio, Finland., Teppo S; Tampere Centre for Child Health Research, University of Tampere and Tampere University Hospital, Tampere, Finland., Bouvy-Liivrand M; Institute of Biomedicine, School of Medicine, University of Eastern Finland, Kuopio, Finland., Lohi O; Tampere Centre for Child Health Research, University of Tampere and Tampere University Hospital, Tampere, Finland., Radaelli E; KU Leuven, Center for Human Genetics, Leuven, Belgium.; VIB, Center for Cancer Biology, Leuven, Belgium., Cools J; KU Leuven, Center for Human Genetics, Leuven, Belgium. jan.cools@kuleuven.vib.be.; VIB, Center for Cancer Biology, Leuven, Belgium.
Publikováno v:
Cancer discovery [Cancer Discov] 2018 May; Vol. 8 (5), pp. 616-631. Date of Electronic Publication: 2018 Mar 01.
Autor:
Girardi T; Department of Oncology, KU Leuven-University of Leuven, LKI-Leuven Cancer Institute, Leuven, Belgium., Vereecke S; Department of Oncology, KU Leuven-University of Leuven, LKI-Leuven Cancer Institute, Leuven, Belgium., Sulima SO; Department of Oncology, KU Leuven-University of Leuven, LKI-Leuven Cancer Institute, Leuven, Belgium., Khan Y; Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD, USA., Fancello L; Department of Oncology, KU Leuven-University of Leuven, LKI-Leuven Cancer Institute, Leuven, Belgium., Briggs JW; Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD, USA., Schwab C; Leukaemia Research Cytogenetics Group, Northern Institute for Cancer Research Newcastle University, Newcastle-upon-Tyne, UK., de Beeck JO; Department of Oncology, KU Leuven-University of Leuven, LKI-Leuven Cancer Institute, Leuven, Belgium., Verbeeck J; Department of Oncology, KU Leuven-University of Leuven, LKI-Leuven Cancer Institute, Leuven, Belgium., Royaert J; Department of Oncology, KU Leuven-University of Leuven, LKI-Leuven Cancer Institute, Leuven, Belgium., Geerdens E; VIB Center for Cancer Biology, Leuven, Belgium.; KU Leuven-University of Leuven, Center for Human Genetics, LKI-Leuven Cancer Institute, Leuven, Belgium., Vicente C; VIB Center for Cancer Biology, Leuven, Belgium.; KU Leuven-University of Leuven, Center for Human Genetics, LKI-Leuven Cancer Institute, Leuven, Belgium., Bornschein S; VIB Center for Cancer Biology, Leuven, Belgium.; KU Leuven-University of Leuven, Center for Human Genetics, LKI-Leuven Cancer Institute, Leuven, Belgium., Harrison CJ; Leukaemia Research Cytogenetics Group, Northern Institute for Cancer Research Newcastle University, Newcastle-upon-Tyne, UK., Meijerink JP; Princess Máxima Center for pediatric oncology, Utrecht, The Netherlands., Cools J; VIB Center for Cancer Biology, Leuven, Belgium.; KU Leuven-University of Leuven, Center for Human Genetics, LKI-Leuven Cancer Institute, Leuven, Belgium., Dinman JD; Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD, USA., Kampen KR; Department of Oncology, KU Leuven-University of Leuven, LKI-Leuven Cancer Institute, Leuven, Belgium., De Keersmaecker K; Department of Oncology, KU Leuven-University of Leuven, LKI-Leuven Cancer Institute, Leuven, Belgium.
Publikováno v:
Leukemia [Leukemia] 2018 Mar; Vol. 32 (3), pp. 809-819. Date of Electronic Publication: 2017 Jul 24.